Medical Scientist Training Program students and twin sisters Lauren Smith, ’15 PhD, and Adrienne Long, ’15 PhD, discuss their recently published research projects and their futures as physician-scientists.
A new study suggests a toxin responsible for seafood-associated sepsis and necrotizing fasciitis may have the ability to treat cancer by destroying the protein Ras.
The impossible is possible when cancer survivors are monitored by medical professionals who know their specialized needs.
A distinct pattern in the changing lengths of telomeres years before cancer diagnoses could yield a new biomarker that predict cancer, according to a new study.
David Gius, MD, PhD, professor in Radiation Oncology and Pharmacology, collaborated with University of Chicago scientists on a study identifying a natural compound that activates the protein SIRT3, a potential target for breast cancer, cardiac conditions and other diseases.
The majority of children who survive cancer in the U.S. face chronic health problems related to their treatment, according to a new Northwestern Medicine study.
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM) when delivered using spherical nucleic acid nanoparticles.
A Northwestern Medicine study found that standard treatments for metastatic melanoma are not effective against Nodal, a growth factor protein critical for the skin cancer’s development, but also showed that combination therapies incorporating anti-Nodal antibodies are a promising alternative.
A Northwestern Medicine study has identified new genetic mutations in patients with Wilms tumor, the most common kidney tumor in children.
In several recent publications, Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, examined how different aspects of transcriptional regulation are involved in cancer development.